Annual EBITDA
$3.93M$30.70M+114.68%
Summary
- Current Value
- As of today, DVAX annual EBITDA is $3.93M, up +114.68% on
- Historical Performance
- DVAX annual EBITDA is down -97.19% over the past 3 years, and up +104.02% over the past 5 years
- All-Time High Comparison
- DVAX annual EBITDA is currently -98.65% below its historical high of $291.41M set on
- 3-Year Low Comparison
- DVAX annual EBITDA is +114.68% above its 3-year low of -$26.77M reached on
- Sector Comparison
- DVAX annual EBITDA is higher than 77.86% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $3.93M | +114.7% | -97.2% | +104.0% | +132.0% | |
| Quarterly EBITDA | $23.37M | +92.5% | -63.1% | +228.3% | +464.6% | |
| TTM EBITDA | $18.68M | +3665.7% | -94.0% | +124.6% | +145.2% | |
| Price | $15.41 | +22.1% | +50.0% | +208.8% | -52.9% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $277.25M | +19.4% | -36.6% | +687.2% | +587.6% | |
| Annual EPS | $0.20 | +512.9% | -62.2% | +109.5% | +102.7% | |
| Annual EBIT | -$4.12M | +87.9% | -103.1% | +96.5% | +72.7% | |
| Annual Net Income | $27.31M | +527.4% | -62.1% | +117.9% | +280.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $291.41M | N/A | -98.7% |
| 5Y | $291.41M | -98.7% | |
| All | $291.41M | -98.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$26.77M | +114.7% | |
| 5Y | -$65.89M | N/A | +106.0% |
| All | -$136.04M | +102.9% |
EBITDA History
FAQ
What is the current annual EBITDA of DVAX?
As of today, DVAX annual EBITDA is $3.93M
What is 1-year change in DVAX annual EBITDA?
DVAX annual EBITDA is up +114.68% year-over-year
What is 3-year change in DVAX annual EBITDA?
DVAX annual EBITDA is down -97.19% over the past 3 years
How far is DVAX annual EBITDA from its all-time high?
DVAX annual EBITDA is currently -98.65% below its historical high of $291.41M set on December 31, 2022
How does DVAX annual EBITDA rank versus sector peers?
DVAX annual EBITDA is higher than 77.86% of companies in Healthcare sector
When is DVAX next annual earnings release?
The next annual earnings release for DVAX is on
Quarterly EBITDA
$23.37M$6.90M+41.88%
Summary
- Current Value
- As of today, DVAX quarterly EBITDA is $23.37M, up +41.88% on
- Historical Performance
- DVAX quarterly EBITDA is up +92.53% year-over-year, and down -63.10% over the past 3 years
- All-Time High Comparison
- DVAX quarterly EBITDA is currently -81.98% below its historical high of $129.67M set on
- 3-Year Low Comparison
- DVAX quarterly EBITDA is +183.78% above its 3-year low of -$27.89M reached on
- Sector Comparison
- DVAX quarterly EBITDA is higher than 82.38% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $23.37M | +41.9% | +92.5% | -63.1% | +228.3% | |
| Annual EBITDA | $3.93M | – | +114.7% | -97.2% | +104.0% | |
| TTM EBITDA | $18.68M | +150.8% | +3665.7% | -94.0% | +124.6% | |
| Price | $15.41 | +48.9% | +22.1% | +50.0% | +208.8% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $94.88M | -0.6% | +17.7% | -43.4% | +607.3% | |
| Quarterly EPS | $0.21 | +52.5% | +81.6% | -52.0% | +237.2% | |
| Quarterly EBIT | $21.27M | +47.4% | +111.0% | -65.6% | +206.6% | |
| Quarterly Net Income | $26.93M | +43.8% | +53.0% | -57.8% | +511.8% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $23.37M | at high | |
| 3Y | $65.22M | N/A | -64.2% |
| 5Y | $129.67M | -82.0% | |
| All | $129.67M | -82.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$21.59M | +208.2% | |
| 3Y | -$27.89M | +183.8% | |
| 5Y | -$27.89M | +183.8% | |
| All | -$34.35M | +168.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of DVAX?
As of today, DVAX quarterly EBITDA is $23.37M
What is DVAX quarterly EBITDA most recent change?
DVAX quarterly EBITDA was up +41.88% on September 30, 2025
What is 1-year change in DVAX quarterly EBITDA?
DVAX quarterly EBITDA is up +92.53% year-over-year
How far is DVAX quarterly EBITDA from its all-time high?
DVAX quarterly EBITDA is currently -81.98% below its historical high of $129.67M set on June 30, 2022
How does DVAX quarterly EBITDA rank versus sector peers?
DVAX quarterly EBITDA is higher than 82.38% of companies in Healthcare sector
When is DVAX next earnings release?
The next earnings release for DVAX is on
TTM EBITDA
$18.68M$11.23M+150.75%
Summary
- Current Value
- As of today, DVAX TTM EBITDA is $18.68M, up +150.75% on
- Historical Performance
- DVAX TTM EBITDA is up +3665.73% year-over-year, and down -93.95% over the past 3 years
- All-Time High Comparison
- DVAX TTM EBITDA is currently -93.95% below its historical high of $308.63M set on
- 3-Year Low Comparison
- DVAX TTM EBITDA is +169.77% above its 3-year low of -$26.77M reached on
- Sector Comparison
- DVAX TTM EBITDA is higher than 77.69% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $18.68M | +150.8% | +3665.7% | -94.0% | +124.6% | |
| Annual EBITDA | $3.93M | – | +114.7% | -97.2% | +104.0% | |
| Quarterly EBITDA | $23.37M | +41.9% | +92.5% | -63.1% | +228.3% | |
| Price | $15.41 | +48.9% | +22.1% | +50.0% | +208.8% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $330.51M | +4.5% | +26.7% | -54.9% | +779.7% | |
| TTM EPS | -$0.38 | +19.5% | -393.3% | -116.7% | +69.8% | |
| TTM EBIT | $10.44M | +1489.9% | +240.2% | -96.5% | +111.9% | |
| TTM Net Income | -$43.40M | +17.7% | -311.9% | -113.5% | +55.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $18.68M | at high | |
| 3Y | $291.41M | N/A | -93.6% |
| 5Y | $308.63M | -94.0% | |
| All | $308.63M | -94.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$980.00K | +2005.9% | |
| 3Y | -$26.77M | +169.8% | |
| 5Y | -$63.85M | N/A | +129.3% |
| All | -$136.07M | +113.7% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of DVAX?
As of today, DVAX TTM EBITDA is $18.68M
What is DVAX TTM EBITDA most recent change?
DVAX TTM EBITDA was up +150.75% on September 30, 2025
What is 1-year change in DVAX TTM EBITDA?
DVAX TTM EBITDA is up +3665.73% year-over-year
How far is DVAX TTM EBITDA from its all-time high?
DVAX TTM EBITDA is currently -93.95% below its historical high of $308.63M set on September 30, 2022
How does DVAX TTM EBITDA rank versus sector peers?
DVAX TTM EBITDA is higher than 77.69% of companies in Healthcare sector
When is DVAX next earnings release?
The next earnings release for DVAX is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- DVAX Official Website www.dynavax.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1029142/000162828025049536/0001628280-25-049536-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1029142/000102914225000049/0001029142-25-000049-index.htm
- DVAX Profile on Yahoo Finance finance.yahoo.com/quote/DVAX
- DVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dvax